5-Aza-2 '-deoxycytidine and interleukin-1 cooperate to regulate matrix metalloproteinase-3 gene expression

INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada.
International Journal of Cancer (Impact Factor: 5.09). 11/2011; 129(9):2083-92. DOI: 10.1002/ijc.25865
Source: PubMed


Members of the matrix metalloproteinase (MMP) family of enzymes play a critical role in extracellular matrix remodeling in a number of normal and pathologic processes. Accordingly, activation of MMP gene expression is tightly regulated at the level of transcription by specific transcription factors, most notably following exposure to inflammatory cytokines. Recent studies with 5-aza-2'-deoxycytidine (5-aza-dC), a specific DNA methylase inhibitor, also suggest that epigenetic processes contribute to the regulation of MMP expression. Although inflammation-related aberrant patterns of DNA methylation have been described, a mechanistic link between inflammation and epigenetic alterations in the control of MMP expression remains unclear. Here, we provide evidence that increased MMP-3 expression by 5-aza-dC is modulated by interleukin-1 (IL-1). More specifically, we found that stimulation with IL-1, but not with IL-6 or TNFα, significantly increased the hypomethylation status of the MMP-3 promoter to a level similar to that found in dnmt1/dnmt3b-deficient HCT116 (DKO) cells. Furthermore, we showed that increased MMP-3 expression by 5-aza-dC was associated with increased expression and activity of specific transcription factors known to regulate MMP-3 expression. In fact, treatment with 5-aza-dC was obligatory for some transcription factors to trigger an increase in MMP-3 expression, such as Ap-1. In contrast, CCAAT enhancer-binding proteins and E-twenty six were capable of inducing MMP-3 alone. Overall, these findings provide a novel perspective of the collaborative role of 5-aza-dC and inflammatory cytokines with specific transcription factors that are normally involved in MMP-3 expression.

Download full-text


Available from: Yves st-pierre, Oct 14, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Matrix metalloproteinase 9 (MMP-9) is one of the most studied enzymes in cancer. MMP-9 can cleave proteins of the extracellular matrix and a large number of receptors and growth factors. Accordingly, its expression must be tightly regulated to avoid excessive enzymatic activity, which is associated with disease progression. Although we know that epigenetic mechanisms play a central role in controlling mmp-9 gene expression, predicting how epigenetic drugs could be used to suppress mmp-9 gene expression is not trivial because epigenetic drugs also regulate the expression of key proteins that can tip the balance towards activation or suppression of MMP-9. Here, we review how our understanding of the biology and expression of MMP-9 could be exploited to augment clinical benefits, most notably in terms of the prevention and management of degenerative diseases and cancer.
    Cellular and Molecular Life Sciences CMLS 11/2012; 70(17). DOI:10.1007/s00018-012-1214-z · 5.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Intrinsic or photo-induced skin aging mainly affects the structural organization of collagen and elastin fibers, the remodeling of which involves proteases such as matrix metalloproteinases (MMPs). Indeed, senescent fibroblasts are characterized by high MMP secretion levels. MMPs display several types of regulation, of which epigenetic modifications may be influenced by the cell environment itself. In addition, amplified oxidative stress following ultraviolet exposure drives MMP expression, leading to transregulation between the dermis and epidermis. Subsequently, the importance of neutrophil elastase in solar elastosis generates a feedback loop, in which elastolysis can mediate collagenolysis through the generation of elastin-derived peptides. Disorganization of dermal collagen and elastin fibers in aged dermis may release peptides containing a GxxPG motif; these are named elastokines as they induce biological effects in a similar way to cytokines. These peptides may have a crucial role in skin inflammaging through the liberation of proinflammatory cytokines, thus leaving the elderly highly susceptible to diseases such as skin cancers, as well as inflammatory and autoimmune diseases.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The link between inflammation and cancer is well established. Chronic inflammation promotes cancer initiation and progression. Various studies showed that the underlying mechanisms involve epigenetic alterations. These epigenetic alterations might culminate into an epigenetic switch that transforms premalignant cells into tumor cells or non-invasive into invasive tumor cells, thereby promoting metastasis. Epigenetic switches require an initiating event, which can be inflammation, whereas the resulting phenotype is inherited without the initiating signal. Epigenetic switches are induced and maintained by DNA methylation, histone modifications, polycomb group (PcG)/trithorax group (TrxG) proteins, and feedback loops consisting of transcription factors and microRNAs. Since epigenetic switches are reversible, they might represent an important basis for the design of novel anticancer therapeutics. This review summarizes published evidence of epigenetic switches in cancer development that are induced by inflammation.
    Cellular and Molecular Life Sciences CMLS 09/2015; DOI:10.1007/s00018-015-2045-5 · 5.81 Impact Factor
Show more